|1.||Yuan, Lin: 7 articles (06/2015 - 05/2005)|
|2.||Hill, Steven M: 6 articles (06/2015 - 05/2005)|
|3.||Mao, Lulu: 6 articles (06/2015 - 11/2008)|
|4.||Frasch, Tripp: 4 articles (06/2015 - 11/2008)|
|5.||Blask, David E: 3 articles (06/2015 - 05/2011)|
|6.||Niles, Lennard P: 3 articles (07/2014 - 03/2007)|
|7.||Lai, Ling: 3 articles (11/2009 - 05/2005)|
|8.||Dong, Chunmin: 3 articles (11/2009 - 05/2005)|
|9.||Hill, S M: 3 articles (04/2007 - 05/2002)|
|10.||Xiang, Shulin: 2 articles (06/2015 - 12/2009)|
|1.||Acute Necrotizing Pancreatitis
11/01/2010 - "[The expression of melatonin MT1 receptor in acute necrotizing pancreatitis rats and the protective effects of melatonin]."
11/01/2010 - "To investigate the expression of melatonin MT1 receptor in rats with acute necrotizing pancreatitis (ANP) and the protective effects of melatonin (MT) pre-intervention for the pancreas. "
04/01/2013 - "Hence, we propose Warthin's tumor as a useful positive control in immunohistochemical studies of MT1 melatonin receptor."
04/01/2013 - "We contribute the first immunohistochemical study of MT1 melatonin receptor in Warthin's tumor and normal parotid gland. "
02/01/2013 - "We designed this study to establish whether a truly inverse relationship exists between tissue-isolated mammary tumor growth in young (2 months), adult (12 months), and old (20 months) female Buffalo rats and the decrease in both MLT and the MT1 receptor with age, such that a causal link could be found. "
05/01/2011 - "In this study, we sought to determine whether the growth of tissue-isolated mammary tumors in young, adult, and old female Buffalo rats relates to the age-related changes in MLT and its MT1 receptor. "
04/01/2013 - "The biological activity of MT1 receptor in epithelial cells lining parotid excretory ducts may resemble its activity in Warthin's tumor cells. "
|3.||Breast Neoplasms (Breast Cancer)
02/01/2013 - "A review of the literature supports the view that MLT, via its MT1 receptor, can suppress all phases of breast cancer including initiation, promotion, and progression. "
11/01/2009 - "Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines."
05/28/2002 - "Involvement of the mt1 melatonin receptor in human breast cancer."
01/10/2003 - "Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice."
12/01/2009 - "The authors have shown that, via activation of its MT1 receptor, melatonin modulates the transcriptional activity of various nuclear receptors and the proliferation of both ER alpha+ and ER alpha- human breast cancer cells. "
|4.||Prostatic Neoplasms (Prostate Cancer)
10/01/2000 - "In this communication, expression of mt1 melatonin receptor protein in human prostate cancer tissues and LNCaP cells was demonstrated by immunohisto(cyto)chemistry and western blotting, hence supporting the use of LNCaP cell line as a model for the study of melatonin signaling in prostate cancer cell growth. "
01/01/2013 - "MT1 receptor-mediated inhibition of activated NF-κB signaling provides a novel mechanism supporting the use of melatonin in prostate cancer chemoprevention and therapy."
01/01/2013 - "Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevention and therapy."
01/01/2001 - "The effects of melatonin on prostate cancer cell proliferation and their association with mt1 receptor expression were investigated in athymic nude mice xenograft models of LNCaP and PC-3 cells. "
10/01/2003 - "As indicated by his PSA levels, melatonin induced stabilization of his hormone-refractory disease for 6 wk. This report validates melatonin's oncostatic action on prostate cancer and the potential involvement of MT1 receptor subtype in the attendant antiproliferative signal transduction as suggested by recent preclinical laboratory findings in a human."
|5.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2014 - "Expression of the MT1 melatonin receptor in ovarian cancer cells."
01/01/2006 - "We were able to detect expression of the MT1 receptor in SK-OV-3 and OVCAR-3 cells and report its up-regulation by melatonin in both ovarian cancer cell lines. "
01/01/2006 - "Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines."
01/01/2006 - "In this study, the effect of antiestrogens on basal and melatonin-modulated expression of MT1 melatonin receptor in breast and ovarian cancer cells was examined. "
01/01/2006 - "In contrast, treatment with 4-OH tamoxifen increased the MT1 receptor level in ERalpha-negative SK-OV-3 ovarian cancer cells. "
|2.||Atrial Natriuretic Factor (ANF)
|3.||Estrogen Receptor alpha
|5.||Estrogen Receptor Modulators (Antiestrogen)
|6.||Progesterone Receptors (Progesterone Receptor)
|9.||GTP-Binding Proteins (G-Protein)
|10.||Valproic Acid (Valproate, Semisodium)
|1.||Heterologous Transplantation (Xenotransplantation)